Table 3. Clinicopathologic parameters of 170 melanoma samples.
| Gender | |
| Male | 109 |
| Female | 61 |
| Anatomic location | |
| Head and neck | 39 |
| Upper limb | 21 |
| Trunk | 55 |
| Lower limb | 31 |
| Non cutaneous | 2 |
| Not stated | 22 |
| TERT promoter status | |
| Wildtype | 39 |
| All mutations | 129 |
| 228C>T | 56 |
| 242CC>TT | 9 |
| 250C>T | 59 |
| 228C>T 250C>T | 2 |
| 242CC>TT 250C>T | 1 |
| 243C>T 250C>T | 1 |
| 228C>T 242CC>TT | 1 |
| Not recorded | 2 |
| Oncogene status | |
| BRAF1 | 67 |
| NRAS | 26 |
| Wildtype | 129 |
| Histologic subtype | |
| Superficial spreading | 85 |
| Nodular | 46 |
| Lentigo maligna melanoma | 9 |
| Melanoma NOS2 | 7 |
| Desmoplastic | 4 |
| Acral lentinginous | 2 |
| MelTUMP3 | 2 |
| Arising from blue nevus | 1 |
| Nevoid | 1 |
| Mucosal | 1 |
| Not recorded | 12 |
| Solar elastosis grade | |
| Grade 0 | 50 |
| Grade 1 | 25 |
| Grade 2 | 28 |
| Grade 3 | 28 |
| Not recorded | 39 |
| Ulceration | |
| Present | 42 |
| Absent | 111 |
| Not recorded | 17 |
| Stage at diagnosis | |
| I | 60 |
| II | 62 |
| III | 36 |
| IV | 8 |
| Not recorded | 4 |
| Breslow thickness | |
| 0.01-1.00mm | 40 |
| 1.01-2.00mm | 36 |
| 2.01-4.00mm | 55 |
| >4.00mm | 26 |
| Not recorded | 13 |
[Table Legend: 1 - canonical BRAF V600 mutations, 2 - Not otherwise specified, 3 - Melanocytic Tumor of Uncertain Malignant Potential]